Adela
About:
Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.
Website: https://www.adelabio.com
Top Investors: OrbiMed, RA Capital Management, F-Prime Capital, Deerfield, LabCorp
Description:
Adela develops innovative and accessible technologies focusing on the detection of cancer and other high-morbidity, high-mortality conditions through a routine blood test. Adela’s genome-wide methylome enrichment platform captures information efficiently from the entire methylome. Its technology distinguishes the most-highly informative (methylated) regions of the genome from non-informative regions and preferentially targets those regions for sequencing.
$108M
$1M to $10M
Foster City, California, United States
2020-01-01
info(AT)adelabio.com
Daniel Carvalho, Maneesh Jain, Scott Bratman
51-100
2023-09-25
Private
© 2025 bioDAO.ai